Yueying Yang

3.5k total citations · 1 hit paper
38 papers, 2.3k citations indexed

About

Yueying Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yueying Yang has authored 38 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Yueying Yang's work include Cancer, Hypoxia, and Metabolism (5 papers), Medicinal Plants and Neuroprotection (4 papers) and Ubiquitin and proteasome pathways (4 papers). Yueying Yang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Medicinal Plants and Neuroprotection (4 papers) and Ubiquitin and proteasome pathways (4 papers). Yueying Yang collaborates with scholars based in China, United States and Russia. Yueying Yang's co-authors include Hua Li, Lixia Chen, Mengzhu Zheng, Canrong Wu, Yang Xu, Yali Wang, Xingzhou Li, Yang Liu, Qiqi Wang and Wu Zhong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Food Chemistry.

In The Last Decade

Yueying Yang

36 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

2020 1.7k citations Canrong Wu, Yang Liu et al. Acta Pharmaceutica Sinica B profile →

Peers

Countries citing papers authored by Yueying Yang

Since Specialization

Citations

This map shows the geographic impact of Yueying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueying Yang more than expected).

Fields of papers citing papers by Yueying Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueying Yang. The network helps show where Yueying Yang may publish in the future.

Co-authorship network of co-authors of Yueying Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yueying Yang. A scholar is included among the top collaborators of Yueying Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueying Yang. Yueying Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cassava Fiber Prevents High-Fat Diet-Induced Obesity in Mice Through Gut Microbiota Restructuring 2025 ·Foods ·Yueying Yang, (unknown), (unknown), Yanhong Chen, Qingqing Li, Jean Long, (unknown), (unknown)	0
2	Design, synthesis and evaluation of the first DYRK1A degrader for promoting the proliferation of pancreatic β-cells 2024 ·Chinese Chemical Letters ·Yueying Yang, (unknown), (unknown), Yang Liu, Hui Wang, Hua Li, Lixia Chen	2
3	Ultrasound-assisted extraction of withanolides from Tubocapsicum anomalum: Process optimization, isolation and identification, and antiproliferative activity 2024 ·Ultrasonics Sonochemistry ·(unknown), Rui Zhu, Yueying Yang, Yang Xu, (unknown), Hua Li, Lixia Chen	2
4	Molecular targets and mechanisms of anti-cancer effects of withanolides 2023 ·Chemico-Biological Interactions ·(unknown), Yueying Yang, Yang Xu, Yang Liu, Hua Li, Lixia Chen	9
5	Cytotoxic withanolides from the stems and leaves of Physalis ixocarpa 2023 ·Food Chemistry ·(unknown), Yan Liu, Rui Zhu, Yang Xu, Dejuan Sun, Yueying Yang, (unknown), Bing‐You Yang, Hua Li, Lixia Chen	3
6	The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer 2023 ·Acta Pharmaceutica Sinica B ·Yang Liu, Wei Xu, Mingxue Li, Yueying Yang, Dejuan Sun, Lidian Chen, Hua Li, Lixia Chen	16
7	SIRT6 mediates multidimensional modulation to maintain organism homeostasis 2022 ·Journal of Cellular Physiology ·Yueying Yang, Man Zhu, Jing Liang, Hui Wang, Dejuan Sun, Hua Li, Lixia Chen	6
8	Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression 2022 ·Journal of Cellular Physiology ·Yanmei Chen, (unknown), Yueying Yang, (unknown), Hua Li, Dejuan Sun, Lixia Chen	17
9	Glutamic oxaloacetic transaminase 1 as a potential target in human cancer 2022 ·European Journal of Pharmacology ·(unknown), Yueying Yang, Yanli Wu, Mengzhu Zheng, Dejuan Sun, Hua Li, Lixia Chen	15
10	Moderate Dose Irradiation Induces DNA Damage and Impairments of Barrier and Host Defense in Nasal Epithelial Cells in vitro 2022 ·Journal of Inflammation Research ·Yueying Yang, Jing Liu, Yitong Liu, (unknown), (unknown), Ce-Belle Chen, Mark Thong, Xinni Xu, (unknown), Qianhui Qiu, De Yun Wang	1
11	Analysis of Intermediate Hosts and Susceptible Animals of SARS-CoV-2 by Computational Methods 2021 ·SHILAP Revista de lepidopterología ·Yueying Yang, Mengzhu Zheng, Yang Liu, Yali Wang, Yang Xu, Yirong Zhou, Dejuan Sun, Lixia Chen, Hua Li	6
12	Discovery of metal-based complexes as promising antimicrobial agents 2021 ·European Journal of Medicinal Chemistry ·Jing Liang, Dejuan Sun, Yueying Yang, Mingxue Li, Hua Li, Lixia Chen	65
13	Targeting SHP2 as a therapeutic strategy for inflammatory diseases 2021 ·European Journal of Medicinal Chemistry ·Yang Liu, Xiaohe Yang, Yali Wang, Yueying Yang, Dejuan Sun, Hua Li, Lixia Chen	24
14	Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1 2021 ·Bioorganic & Medicinal Chemistry ·Yueying Yang, (unknown), Dejuan Sun, Mengzhu Zheng, (unknown), (unknown), Xuanbin Wang, Hua Li, Lixia Chen	10
15	Chemistry and bioactivity of plants from the genus Amomum 2021 ·Journal of Ethnopharmacology ·(unknown), (unknown), Yali Wang, Yueying Yang, Dejuan Sun, Hua Li, Lixia Chen	34
16	3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment 2021 ·Cellular Oncology ·Mingxue Li, Canrong Wu, Yueying Yang, Mengzhu Zheng, (unknown), Jinhui Wang, Lixia Chen, Hua Li	29
17	PROTACs: New method to degrade transcription regulating proteins 2020 ·European Journal of Medicinal Chemistry ·(unknown), Yirong Zhou, Dejuan Sun, Yueying Yang, Yang Liu, Xingzhou Li, Hua Li, Lixia Chen	32
18	Furin: A Potential Therapeutic Target for COVID-19 2020 ·iScience ·Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, (unknown), Yang Liu, Qingzhe Zhang, Peng Zhang, Yali Wang, Qiqi Wang, Yang Xu, Yirong Zhou, Yonghui Zhang, Lixia Chen, Hua Li	141
19	Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor 2020 ·Journal of Medicinal Chemistry ·Weiguang Sun, Yanli Wu, Mengzhu Zheng, Yueying Yang, Yang Liu, Canrong Wu, Yirong Zhou, Yonghui Zhang, Lixia Chen, Hua Li	23
20	Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods breakdown → 2020 ·Acta Pharmaceutica Sinica B ·Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, (unknown), Xingzhou Li, Mengzhu Zheng, Lixia Chen, Hua Li	1653

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact